A decision regarding the reclassification of marijuana in the United States is expected to be delayed until after the upcoming November presidential election, potentially making it a significant political topic during the closely contested race. The U.S. Drug Enforcement Administration has scheduled a hearing for December 2 to gather comments on the proposed change in federal drug policy.
It is anticipated that the final decision on the reclassification may come under the next administration, with cannabis lawyer Brian Vicente noting that such a decision before President Joe Biden’s term concludes would be considered expedited. The presidential candidates’ stances on marijuana could receive heightened attention as Vice President Kamala Harris has supported decriminalization and questioned its classification as a Schedule I drug alongside heroin and LSD.
Former President Donald Trump, the Republican nominee, has shown some support for marijuana legalization, highlighting shifting attitudes towards the drug’s legality. The proposal to reclassify marijuana by the Justice Department in May aimed to acknowledge its medical uses and lower potential for abuse compared to other dangerous drugs. This move came after a request for review from President Biden, who views the change as monumental.
While the DEA has not taken a definitive position on the reclassification, the proposal marks a significant potential shift in U.S. drug policy, likely to influence younger voters. Opposition from groups like Smart Approaches to Marijuana exists, with claims that there is insufficient data to support reclassifying cannabis to a less dangerous category.
The delay in the decision-making process has caused concerns among industry players, with some expressing disappointment in the slow progress. Advocates for legalization hope that rescheduling marijuana could lead to improvements in banking access for cannabis companies and research opportunities. However, there are concerns that the industry’s focus on benefits and potential profits could overshadow the well-being of those who could benefit from medical marijuana.
The reclassification of marijuana could have various implications, from tax deductions for pot companies to changes in the criminal justice system. With federal and state laws around marijuana evolving at different paces, the future of marijuana policy in the United States remains a topic of ongoing debate and contention.
